|
Volumn 91, Issue 5, 2002, Pages 540-545
|
Multiple doses of secretin in the treatment of autism: A controlled study
|
Author keywords
Autism; Placebo controlled; Secretin; Treatment
|
Indexed keywords
SECRELUX;
SECRETIN;
ARTICLE;
AUTISM;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT FAILURE;
VISUAL ANALOG SCALE;
APPETITE;
DRUG EFFECT;
FOLLOW UP;
INTELLIGENCE TEST;
INTRAVENOUS DRUG ADMINISTRATION;
SLEEP;
SOCIAL BEHAVIOR;
TIME;
VERBAL BEHAVIOR;
APPETITE;
AUTISTIC DISORDER;
CHILD;
CROSS-OVER STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
INJECTIONS, INTRAVENOUS;
INTELLIGENCE TESTS;
MALE;
SECRETIN;
SLEEP;
SOCIAL BEHAVIOR;
SUPPORT, NON-U.S. GOV'T;
TIME FACTORS;
VERBAL BEHAVIOR;
HUMANS;
|
EID: 0036275844
PISSN: 08035253
EISSN: None
Source Type: Journal
DOI: 10.1080/080352502753711669 Document Type: Article |
Times cited : (24)
|
References (20)
|